World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
29522
World Ranking
15480
National Ranking
1426

Peter C. Taylor publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter C. Taylor sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 520 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter C. Taylor D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter C. Taylor sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter C. Taylor is affiliated with the University of Oxford in the United Kingdom and specializes in the field of Medicine, with a primary focus on Rheumatology. Their research portfolio includes a substantial number of publications in this subfield, supported by additional expertise in Hematology, Genetics, Immunology, and Pathology and Forensic Medicine.

The research work of Peter C. Taylor predominantly addresses topics related to Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research, and Chronic Lymphocytic Leukemia Research. Other notable topics include Systemic Lupus Erythematosus Research, Spondyloarthritis Studies and Treatments, Lymphoma Diagnosis and Treatment, and Cytokine Signaling Pathways and Interactions.

Among their recent published papers are:

  • Neutralizing monoclonal antibodies for treatment of COVID-19, 2021, published in Nature reviews. Immunology
  • Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database, 2021, published in Annals of the Rheumatic Diseases

Peter C. Taylor has collaborated frequently with a community of researchers active in related fields. Frequent co-authors include Tsutomu Takeuchi, Yoshiya Tanaka, Ewa Haładyj, Bruno Fautrel, and Gerd R Burmester.

Their publications have been featured most often in the following venues:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Endocrine Abstracts
  • Rheumatology and Therapy
  • RMD Open

These journals highlight a consistent involvement in rheumatology and related clinical therapeutic research domains.

Best Publications

  • Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events.

    F D Loop;B W Lytle;D M Cosgrove;R W Stewart

  • Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

    R N Maini;P C Taylor;J Szechinski;K Pavelka

  • Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

    Peter C. Taylor;Edward C. Keystone;Désirée van der Heijde;Michael E. Weinblatt

  • Neutralizing monoclonal antibodies for treatment of COVID-19.

    Peter C. Taylor;Andrew C. Adams;Matthew M. Hufford;Inmaculada de la Torre

  • Anti-TNF therapy: past, present and future

    Claudia Monaco;Jagdeep Nanchahal;Peter Taylor;Marc Feldmann

  • Anti-cytokine therapy for rheumatoid arthritis.

    R N Maini;P C Taylor

  • Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.

    Peter C. Taylor;Marc Feldmann

  • Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

    X Mariette;M Matucci-Cerinic;K Pavelka;P Taylor

  • Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.

    P P Tak;P C Taylor;F C Breedveld;T J Smeets

  • Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

    P C Taylor;A M Peters;E Paleolog;P T Chapman

  • Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis.

    Andrew Kinloch;Verena Tatzer;Robin Wait;David Peston

  • Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis†

    P. C. Taylor;A. Steuer;J. Gruber;D. O. Cosgrove

  • Diagnosis and management of acute graft-versus-host disease.

    Fiona L. Dignan;Andrew Clark;Persis Amrolia;Jacqueline Cornish

  • Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes

    Myles J. Lewis;Michael R. Barnes;Michael R. Barnes;Kevin Blighe;Katriona Goldmann

  • Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.

    Sundeept Ballara;Peter C. Taylor;Petra Reusch;Dieter Marmé

  • The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

    Andreas Reiter;Christoph Walz;Ann Watmore;Claudia Schoch

  • Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate

    Edward C Keystone;Peter C Taylor;Edit Drescher;Douglas E Schlichting

  • Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

    Ravinder N. Maini;Michael J. Elliott;Fionula M. Brennan;Richard O. Williams

  • Human neutrophils secrete vascular endothelial growth factor.

    Norton S. Taichman;Sylvia Young;Alan T. Cruchley;Peter Taylor

  • A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective.

    Peter C. Taylor;Adam Moore;Radu Vasilescu;Jose Alvir

Frequent Co-Authors

Iain B. McInnes
Iain B. McInnes University of Glasgow
Christopher D. Buckley
Christopher D. Buckley University of Oxford
Paul Emery
Paul Emery University of Leeds
Marc Feldmann
Marc Feldmann University of Oxford
Costantino Pitzalis
Costantino Pitzalis Queen Mary University of London
Michele Bombardieri
Michele Bombardieri Queen Mary University of London
Mark C. Genovese
Mark C. Genovese Stanford University
Ravinder N. Maini
Ravinder N. Maini Imperial College London
Ewa M. Paleolog
Ewa M. Paleolog University of Oxford
Richard O. Williams
Richard O. Williams University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean attending traditional, in-person programs. Today, there are a variety of online degree options and career pathways that can help you advance or change your role within healthcare—even from home.

Nurses looking to move up often consider bridge programs. For example, if you’re already an RN, pursuing an rn to bsn online with no clinicals can save time and fit into a busy work schedule. Those aiming even higher may look at advanced roles through the fastest dnp program or search for the cheapest online dnp programs to gain a doctorate in nursing with less financial burden.

Additionally, learners can enter the medical field quickly through options like a fast track lpn, which can lead to practical nursing jobs in less time than traditional programs.

Online healthcare programs can be flexible, accelerated, and affordable—but students should consider accreditation, program requirements, and career goals before enrolling. These options open new doors for anyone passionate about making a difference in medicine.

Best Scientists Citing Peter C. Taylor

Trending Scientists